June 16, 2022 | Advocacy, Life with MS, Treatments
Multiple Sclerosis NZ is pleased to see the announcement this week from Pharmac to provide access to funded MS treatments earlier than ever before. The new criteria will no longer require those clinically diagnosed with MS to wait for […]
June 8, 2022 | Covid-19, Treatments
If you have tested positive for COVID-19 and your symptoms started in the past 5 days and you are on Fingolimod or Ocrelizumab for your MS, you may be eligible for antiviral medication to treat COVID-19. Your GP can prescribe […]
May 30, 2022 | Advocacy, Life with MS, Treatments
We are excited to announce that following 7 years of relentless advocacy by Multiple Sclerosis NZ (MSNZ), Pharmac have opened the consultation process to increase earlier access to treatments for relapsing remitting MS. We now need YOUR HELP to get […]
May 23, 2022 | Media, Treatments
Media article: 19 May 2022 Pharmac welcomes the $191 million increase to its pharmaceutical budget over the next two years. It is already working its way through the medicines options for investment (OFI) list, looking at what agreements it can […]
May 23, 2022 | Advocacy, Life with MS, My Story, Treatments
Lucy Kerly had aHSCT on the NHS at Hammersmith Hospital in London at the beginning of 2022. Both she and her husband live with MS – Steve was diagnosed with relapsing MS in 2003 when he was 29 and travelled […]